Findings presented here establish a novel t(8;21) AML leukemia signature characterized by occupancy of AML1-ETO/N-CoR at promoter-distal genomic regions enriched in motifs for myeloid differentiation factors. This evidence concerns the gene RUNX1 and leukemia.